Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2019-08-19
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the safety and tolerability of sotagliflozin after a multiple oral dose
administration in Chinese healthy subjects.
Secondary Objectives:
- To assess the pharmacokinetic (PK) parameters of sotagliflozin after a multiple oral
dose administration in Chinese healthy subjects.
- To assess the pharmacodynamics (PD) parameters of absolute urinary glucose excretion
after a multiple oral dose administration in Chinese healthy subjects.